![]() Amarin Amarin Corporation is a pharmaceutical company that engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases. | ![]() BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions. | ![]() Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients. | ||
Founding Date | Founding Date 1991 | Founding Date 1997 | Founding Date 1904 | Founding Date 1951 |
Type | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations Dublin, IE HQ Zug, CH Bridgewater Township, US | Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | |
Employees | Employees 275 | Employees 3,0015% increase | Employees 7,5692% decrease | Employees 8,5201% increase |
Valuation ($) | Valuation ($) 257.6 m | Valuation ($) 13.3 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $213.6m (FY, 2025) | Revenue (est.) $3.2b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) N/A |
Gross profit | Gross profit $120.9m (FY, 2025) | Gross profit $2.5b (FY, 2025) | Gross profit $4.5b (FY, 2020) | Gross profit N/A |
Net income | Net income ($38.8m) (FY, 2025) | Net income $348.9m (FY, 2025) | Net income N/A | Net income N/A |
Operating ⚠ | ||||
Patent Applications | Patent Applications N/A | Patent Applications 426 (FY, 2016) | Patent Applications 3 (Dec, 2020) | Patent Applications N/A |

BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions.
View company
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
View company